Biomedical Human Kinetics, an esteemed academic journal published by SCIENDO, focuses on the intricate intersections of human movement, rehabilitation, and the study of physical therapies. Since its transition to an open access model in 2009, this journal has become a vital platform for sharing groundbreaking research and innovative methodologies in the fields of Orthopedics, Sports Medicine, and Physical Therapy. With an ISSN of 0043-9630 and an E-ISSN of 2080-2234, it operates out of Poland, providing global access to high-quality research. The journal’s standing in 2023 is notable, ranking in the Q3 category for both Orthopedics and Sports Medicine and Physical Therapy, Sports Therapy, and Rehabilitation, reflecting its commitment to fostering academic discourse within these important and evolving domains. Furthermore, with Scopus rankings placing it in the 36th percentile in its categories, Biomedical Human Kinetics is recognized for its contributions to the academic community. As it converges research efforts from 2016 to 2024, this journal serves as a cornerstone for researchers, professionals, and students dedicated to enhancing human health and performance through informed scientific exploration.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

Neuron is a premier journal in the field of neuroscience, published by CELL PRESS in the United States. Since its inception in 1988, this esteemed publication has been at the forefront of neuroscientific research and continues to shape our understanding of the brain and nervous system. With an impressive 2023 Scopus rank of #5 out of 113 in General Neuroscience and a notable Q1 quartile classification, Neuron is recognized for its high-quality, impactful contributions to both established and emerging areas of neuroscience. The journal does not operate under an open access model, yet it offers unparalleled insights and rigorous peer-reviewed research that are essential for researchers, professionals, and students alike. By publishing cutting-edge findings and fostering critical discussions, Neuron plays a vital role in advancing our collective knowledge in this constantly evolving field, making it an indispensable resource for anyone aiming to stay ahead in neuroscience research.

Welcome to the JOURNAL OF VASCULAR RESEARCH, a reputable academic journal published by KARGER that has been a cornerstone of vascular research since 1964. With an ISSN of 1018-1172 and an E-ISSN of 1423-0135, this journal plays a vital role in disseminating cutting-edge research in the fields of Cardiology and Cardiovascular Medicine and Physiology. Currently categorized in the Q3 quartile for both disciplines, it ranks as #179 in Cardiology and #131 in Physiology according to Scopus, showcasing its significant contribution to the scientific community. Although the journal operates on a subscription basis, it strives to provide accessible content that informs and inspires researchers, professionals, and students alike. As the journal looks forward to its convergence in 2024, it continues to uphold its mission of advancing knowledge, fostering innovation, and encouraging collaboration within the dynamic realm of vascular research.

The Journal of Electromyography and Kinesiology, published by Elsevier, is a distinguished academic platform that focuses on the intricate interrelations between electromyography, kinetic analysis, and their applications in health and sports sciences. Established in 1991, this journal has maintained a rigorous publication standard and continues to be pivotal in advancing knowledge in biophysics, neurology, and sports science, with impressive Q1 and Q2 ratings in multiple categories as of 2023. With an impact factor that underscores its significance in the scientific community, the journal contributes to a deeper understanding of muscle function and movement patterns, making it an essential resource for researchers, healthcare professionals, and students alike. While it operates under a subscription model, the insights provided by the journal are invaluable for anyone invested in the fields of biomechanics, rehabilitation, and neuromuscular research. For over three decades, this journal has become a cornerstone for disseminating groundbreaking research and fostering collaboration among scholars in the ever-evolving landscape of kinesiology and electromyography.

The Journal of Cachexia Sarcopenia and Muscle is a premier open-access publication dedicated to advancing the understanding of muscle wasting, cachexia, and related disorders. Published by Wiley, this esteemed journal boasts an impressive impact within its fields, achieving a Q1 classification in both Orthopedics and Sports Medicine, and Physiology (Medical) for 2023. With a Scopus ranking of #4 out of 321 in Orthopedics and Sports Medicine, and #10 out of 113 in Physiology, it firmly positions itself at the forefront of medical research. The journal’s scope includes comprehensive studies, reviews, and innovative clinical trials that contribute to the scientific community’s understanding of muscle health and performance. Since its inception in 2010 as an open-access platform, the Journal of Cachexia Sarcopenia and Muscle has facilitated a growing dialogue among researchers, healthcare professionals, and students, emphasizing its crucial role in tackling the multifaceted challenges posed by muscle diseases. For those invested in the latest research trends and clinical advancements, this journal stands out as a vital resource and reference point.

CELL CALCIUM is a premier journal published by ELSEVIER SCI LTD, focusing on the critical role of calcium in cellular processes, making it an essential read for researchers and professionals in the fields of Cell Biology, Molecular Biology, and Physiology. Having been in publication since 1980, this journal is well-regarded, holding a Q2 ranking in Cell Biology and Molecular Biology, as well as a prestigious Q1 status in Physiology for 2023. With an impressive Scopus ranking that places it in the top 20% of journals in its categories, CELL CALCIUM aims to disseminate original research articles that advance the understanding of calcium signaling mechanisms and their implications in health and disease. Although not available via open access, its insights are critical for advancing knowledge and fostering collaboration within the scientific community. The journal is located in the United Kingdom, with its editorial excellence helping to promote high-impact research that continues to influence both academia and industry.

JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, published by Springer in the Netherlands, serves as a pivotal platform for disseminating high-quality research within the fields of physiology, biochemistry, and related biomedical sciences. With an impressive impact factor reflected in its categorization as Q2 in Biochemistry and Q1 in Medicine (miscellaneous), this journal fosters a vibrant community of scholars dedicated to advancing knowledge and innovation. The journal’s broad scope encompasses a wide range of topics from cellular mechanisms to systemic physiology, making it relevant for both theoretical and applied sciences. Researchers and practitioners are encouraged to utilize the available Open Access options to reach a wider audience. The journal’s continuous contribution to the scientific dialogue since its inception in 1996 positions it as a key resource for professionals and students alike, facilitating the exploration of cutting-edge topics and collaborative research opportunities.

JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, published by JMNI in Greece, serves as a vital platform for disseminating cutting-edge research in the fields of musculoskeletal and neuronal sciences. Established in 2002, this journal has continued to evolve, presenting studies that bridge the critical interactions between musculoskeletal health and neuronal function. With a current impact factor reflected in its rankings, it holds a Q3 classification in Endocrinology, Diabetes and Metabolism, and a Q2 classification in Orthopedics and Sports Medicine, alongside Q3 in Physiology, placing it prominently within the academic landscape. The journal's accessibility, while not officially labeled as Open Access, ensures that valuable research findings are available to an international audience of researchers, professionals, and students committed to advancing the understanding of human health. The depth and breadth of content in the JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS underscore its importance in fostering innovation and collaboration across related disciplines, making it a must-read for those invested in the future of musculoskeletal and neuronal research.

Physiological Genomics is a prestigious scholarly journal published by the American Physiological Society, dedicated to advancing the understanding of the genetic underpinnings in physiology. With an ISSN of 1094-8341 and an E-ISSN of 1531-2267, this journal serves as a vital platform for researchers exploring the intersection of genetics and physiological processes. As of 2023, it enjoys a respectable impact factor, particularly standing strong in the Q2 quartile in both Genetics and Physiology categories, illustrating its importance within a competitive landscape. With an impressive rank of #69 out of 193 in Biochemistry, Genetics, and Molecular Biology - Physiology, and #128 out of 347 in Genetics, it reflects a robust commitment to quality research. Committed to fostering innovation, Physiological Genomics provides comprehensive access to groundbreaking studies from 1999 to 2024 and remains a quintessential resource for researchers, professionals, and students alike aiming to enhance their understanding of physiological genomics.